Zuellig Pharma Acquires Cialis® (Tadalafil) from Lilly in Singapore
SINGAPORE – Media OutReach Newswire – 3 August 2026 – Zuellig Pharma, a leading healthcare solutions company in Asia, today announced that it has acquired all rights, title, and interest in and to Cialis®(Tadalafil), a leading men’s health product from Eli Lilly and Company (“Lilly”) in Singapore.
Following the acquisition, Zuellig Pharma will now own the trademarks and marketing authorizations and licenses manufacturing know-how for Cialis®, a treatment for erectile dysfunction (ED) and benign prostatic hyperplasia (BPH), in 12 markets in Asia, with the expansion of its ownership into Singapore. Zuellig Pharma will also continue to promote and distribute the brand in these 12 markets.
The expanded ownership of Cialis® will widen accessibility of the drug to a significant population of men in Asia who are affected by ED and BPH. The acquisition also aligns with Zuellig Pharma’s strategic priority of building a strong portfolio of owned healthcare products as an integrated healthcare solutions company.
“Acquiring Cialis® in Singapore is a reflection of our proven expertise in growing world-class healthcare brands. This strategic move builds on our strong performance; true to our core purpose: to make essential healthcare more accessible for communities across Asia. We are driving sustainable growth by focusing on what matters most – the health of the people we serve”, said John Graham, CEO of Zuellig Pharma.
The issuer is solely responsible for the content of this announcement.
About Zuellig Pharma
Zuellig Pharma is a leading healthcare solutions company in Asia, and our purpose is to make healthcare more accessible to the communities we serve. We provide world-class distribution, commercialization, and clinical trial support services, underpinned by a strong culture of innovation to support the growing healthcare needs in this region. The company was founded a hundred years ago and has grown to become a multibillion-dollar business covering 18 markets with over 12,000 employees. Our people serve more than 200,000 medical facilities and work with over 450 clients, including the top 20 pharmaceutical companies in the world.
Related
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
https://www.linkedin.com/company/zuellig-pharma
